Skip to main content

A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Open
  • Protocol code: SNDX-6352-0506
  • EudraCT code: No aplica
  • Research group: Psychiatry, Mental Health and Addictions
  • Service: Psychiatry
  • Principal investigator:  Villar Moreno, Ana M
  • Pathology: Malalties del sistema respiratori
  • Phase: Fase II
  • Status: Recruiting volunteers